Dimethyl fumarate may still have a role in progressive multiple sclerosis

by Domenico Plantone, Floriana De Angelis, Anisha Doshi, Jeremy Chataway
Published 2016-07-01

Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis [version 1; referees: 1 approved, 2 approved with reservations]

by Alex Lewin, Shea Hamilton, Aviva Witkover, Paul Langford, Richard Nicholas, Jeremy Chataway, Charles R.M. Bangham
Published 2016-11-01

Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis [version 2; referees: 1 approved, 2 approved with reservations]

by Alex Lewin, Shea Hamilton, Aviva Witkover, Paul Langford, Richard Nicholas, Jeremy Chataway, Charles R.M. Bangham
Published 2016-12-01

A predictive model for corticosteroid response in individual patients with MS relapses.

by Martin Rakusa, Stefan J Cano, Bernadette Porter, Afsane Riazi, Alan J Thompson, Jeremy Chataway, Todd A Hardy
Published 2015-01-01

Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis

by Jeremy Chataway, Tarek Yousry, Matthew Walker, Michael S Zandi, Michael P Lunn, Robin S Howard, Jennifer Spillane, Bernadette Monaghan, Kushan Karunaratne, Dariush Ahrabian, Tom Campion, Dimitri M Kullmann
Published 2021-05-01

Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.

by Hanna M Vesterinen, Peter Connick, Cadi M J Irvine, Emily S Sena, Kieren J Egan, Gary G Carmichael, Afiyah Tariq, Sue Pavitt, Jeremy Chataway, Malcolm R Macleod, Siddharthan Chandran
Published 2015-01-01

Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic e...

by Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Nancy Chiaravalloti, Ulrik Dalgas, John DeLuca, Peter Feys, Massimo Filippi, Jennifer Freeman, Cecilia Meza, Matilde Inglese, Robert W. Motl, Maria Assunta Rocca, Brian M. Sandroff, Amber Salter, Gary Cutter, On behalf of the CogEx Research Team
Published 2020-05-01

Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT

by Floriana De Angelis, Peter Connick, Richard A Parker, Domenico Plantone, Anisha Doshi, Nevin John, Jonathan Stutters, David MacManus, Ferran Prados, Ian Marshall, Bhavana Solanky, Rebecca S Samson, Frederik Barkhof, Sebastien Ourselin, Marie Braisher, Moira Ross, Gina Cranswick, Sue H Pavitt, Sharmilee Gnanapavan, Gavin Giovannoni, Claudia AM Gandini Wheeler-Kingshott, Clive Hawkins, Basil Sharrack, Roger Bastow, Christopher J Weir, Nigel Stallard, Siddharthan Chandran, Jeremy Chataway
Published 2020-05-01